TIMI Risk Index and the Benefit of Enoxaparin in Patients with ST-Elevation Myocardial Infarction

Author:

Ruff Christian T.,Wiviott Stephen D.,Morrow David A.,Mohanavelu Satishkumar,Murphy Sabina A.,Antman Elliott M.,Braunwald Eugene

Publisher

Elsevier BV

Subject

General Medicine

Reference16 articles.

1. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction;Antman;N Engl J Med,2006

2. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction;Antman;Am Heart J,2005

3. A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy;Morrow;Lancet,2001

4. Performance of the Thrombolysis In Myocardial Infarction Risk Index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction;Wiviott;J Am Coll Cardiol,2004

5. The meaning and use of the area under a receiver operating characteristic (ROC) curve;Hanley;Radiology,1982

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3